| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 163.07B | 160.05B | 141.85B | 124.66B | 114.72B | 132.92B |
| Gross Profit | 25.80B | 24.67B | 20.16B | 17.39B | 14.78B | 21.73B |
| EBITDA | 18.64B | 18.29B | 14.42B | 11.39B | 9.19B | 15.31B |
| Net Income | 11.87B | 11.56B | 8.30B | 7.91B | 5.33B | 9.69B |
Balance Sheet | ||||||
| Total Assets | 155.41B | 181.12B | 168.12B | 149.70B | 136.67B | 141.70B |
| Cash, Cash Equivalents and Short-Term Investments | 32.56B | 15.71B | 16.38B | 13.61B | 25.79B | 31.69B |
| Total Debt | 3.43B | 10.66B | 10.78B | 5.88B | 982.64M | 1.09B |
| Total Liabilities | 35.11B | 60.34B | 56.63B | 46.21B | 38.14B | 44.95B |
| Stockholders Equity | 119.10B | 119.62B | 110.43B | 102.38B | 97.13B | 95.42B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.48B | 973.22M | -14.45B | -3.12B | 16.56B |
| Operating Cash Flow | 0.00 | 4.16B | 4.84B | -8.96B | 3.09B | 21.12B |
| Investing Cash Flow | 0.00 | -1.25B | -3.68B | -4.96B | -5.83B | -3.66B |
| Financing Cash Flow | 0.00 | -3.58B | 1.61B | 1.75B | -3.17B | -3.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥188.65B | 10.32 | ― | 3.44% | 11.25% | 36.92% | |
76 Outperform | ¥259.31B | 12.19 | 7.43% | 2.78% | 1.31% | 59.20% | |
75 Outperform | ¥236.39B | 8.46 | ― | 3.82% | -3.72% | 59.02% | |
72 Outperform | ¥699.53B | 12.93 | ― | 2.15% | -5.20% | -1.20% | |
71 Outperform | ¥184.07B | 9.99 | ― | 2.87% | 6.66% | 46.38% | |
66 Neutral | ¥199.22B | 12.14 | ― | 3.09% | 3.75% | 87.00% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |